Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 74

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Drug–drug interactions that interfere with statin metabolism

Hirota, Takeshi, Ieiri, Ichiro · 2015 · Expert Opinion on Drug Metabolism & Toxicology

Abstract

INTRODUCTION: Lipid-lowering drugs, especially hydroxymethylglutaryl-CoA reductase inhibitors (statins), are widely used in the treatment and prevention of atherosclerotic diseases. The benefits of statins are well documented. However, myotoxic side effects, which can sometimes be severe, including myopathy or rhabdomyolysis, have been associated with the use of statins. In some cases, this toxicity is associated with pharmacokinetic alterations. Potent inhibitors of CYP 3A4 significantly increase plasma concentrations of the active forms of simvastatin, lovastatin and atorvastatin. Fluvastatin is metabolized by CYP2C9, while pravastatin, rosuvastatin and pitavastatin are not susceptible to inhibition by any CYP. AREAS COVERED: This review discusses the pharmacokinetic aspects of the drug-drug interaction with statins and genetic polymorphisms in CYPs, which are involved in the metabolism of statins, and highlights the importance of establishing a system utilizing electronic medical information practically to avoid adverse drug reactions. EXPERT OPINION: An understanding of the mechanisms underlying statin interactions will help to minimize drug interactions and develop statins that are less prone to adverse interactions. Quantitatively analyzed information for the low-density lipoprotein cholesterol lowering effects of statin based on electronic medical records may be useful for avoiding the adverse effect of statins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/17425255.2015.1056149

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 128

  1. Rodwell VW, 1976, Adv Lipid Res, 14, 1, 10.1016/B978-0-12-024914-5.50008-5 · DOI · Paper page
  2. 10.1038/343425a0 · DOI · Paper page
  3. 10.1016/0014-5793(76)80996-9 · DOI · Paper page
  4. 10.1186/CVM-2-5-205 · DOI · Paper page
  5. 10.1002/pds.977 · DOI
  6. 10.2165/00002018-200225090-00004 · DOI · Paper page
  7. 10.1002/pds.1895 · DOI
  8. 10.1016/0002-9149(88)90004-5 · DOI · Paper page
  9. 10.1001/archinte.1996.00440170097011 · DOI · Paper page
  10. 10.2165/00002018-200730020-00005 · DOI
  11. 10.1002/tera.1420500104 · DOI
  12. 10.1006/taap.1997.8174 · DOI
  13. 10.1016/S0022-2828(95)92163-X · DOI
  14. Smith PF, 1991, J Pharmacol Exp Ther, 257, 1225, 10.1016/S0022-3565(25)24759-0 · DOI
  15. 10.1016/S0002-9149(96)00742-4 · DOI · Paper page
  16. 10.1248/bpb.20.104 · doi:10.1248/bpb.20.104
  17. Molden E, 2007, Tidsskr Nor Laegeforen, 127, 1660
  18. 10.1161/CIRCULATIONAHA.106.624890 · DOI · Paper page
  19. Nakai D, 2001, J Pharmacol Exp Ther, 297, 861, 10.1016/S0022-3565(24)29609-9 · DOI · Paper page
  20. 10.1016/j.amjcard.2005.12.007 · DOI · Paper page
  21. 10.2165/00002512-200724050-00006 · DOI
  22. 10.1517/14740338.5.1.145 · DOI
  23. 10.1007/BF03167690 · DOI
  24. 10.1345/aph.1A333 · doi:10.1345/aph.1a333 · Paper page
  25. 10.1146/annurev.pa.32.040192.001153 · DOI · Paper page
  26. 10.1038/clpt.2008.165 · DOI
  27. 10.2165/00003088-200241050-00003 · DOI · Paper page
  28. 10.1016/j.pharmthera.2006.03.003 · DOI · Paper page
  29. 10.2165/00003088-200847070-00003 · DOI · Paper page
  30. 10.2165/00003088-200342130-00005 · DOI · Paper page
  31. 10.1007/s002280100329 · DOI · Paper page
  32. 10.1093/qjmed/hcn089 · DOI
  33. 10.1016/j.clpt.2006.09.003 · DOI · Paper page
  34. 10.2165/00003088-200039060-00002 · DOI · Paper page
  35. 10.1177/009127002401102876 · DOI
  36. 10.1515/DMDI.2004.20.1-2.25 · DOI
  37. 10.1016/j.atherosclerosis.2010.10.006 · DOI
  38. 10.1080/03602530701836662 · DOI
  39. 10.1007/s00216-008-2291-6 · DOI · Paper page
  40. 10.1080/00498250802334391 · DOI
  41. 10.1097/00041433-200212000-00007 · DOI
  42. 10.1016/j.amjcard.2003.08.078 · DOI
  43. 10.1093/jnci/90.16.1225 · DOI · Paper page
  44. 10.1016/S0009-9236(99)70037-8 · DOI · Paper page
  45. 10.1006/bbrc.1999.0752 · DOI · Paper page
  46. 10.1067/mcp.2000.104391 · doi:10.1067/mcp.2000.104391
  47. 10.1067/mcp.2000.108506 · DOI · Paper page
  48. 10.1097/00008571-200107000-00008 · DOI
  49. Moes DJ, 2014, CPT, 3, e100
  50. 10.2174/138920008783331130 · doi:10.2174/138920008783331130
  51. 10.1038/86882 · DOI · Paper page
  52. 10.1097/01.fpc.0000114762.78957.a5 · DOI · Paper page
  53. 10.1016/j.clpt.2005.08.003 · DOI · Paper page
  54. 10.1080/00498250500256367 · doi:10.1080/00498250500256367
  55. 10.1016/S0009-9236(03)00121-8 · DOI
  56. 10.12659/MSM.883272 · doi:10.12659/msm.883272
  57. 10.1023/A:1011077109233 · DOI
  58. 10.1592/phco.27.4.603 · DOI
  59. 10.1016/j.amjcard.2004.07.080 · DOI · Paper page
  60. 10.1592/phco.20.13.1066.35033 · DOI
  61. 10.1016/S0140-6736(05)78613-X · DOI
  62. 10.1016/S0006-2952(95)02175-2 · DOI
  63. Regazzi MB, 1993, Transplant Proc, 25, 2732
  64. 10.1016/j.clpt.2003.09.011 · DOI
  65. 10.2165/00003495-200363040-00003 · DOI
  66. 10.1016/j.clpt.2004.03.010 · DOI · Paper page
  67. 10.1124/dmd.106.009290 · DOI · Paper page
  68. 10.1067/mcp.2002.128469 · DOI · Paper page
  69. 10.1007/s002280050408 · DOI
  70. 10.1046/j.1365-2362.33.s2.6.x · DOI · Paper page
  71. 10.1007/s002280000127 · DOI
  72. 10.1046/j.1365-2796.1999.00610.x · DOI
  73. 10.1177/009127002401102731 · DOI
  74. 10.1097/MOL.0b013e3280555083 · DOI
  75. 10.1124/dmd.30.11.1280 · DOI · Paper page
  76. 10.1007/s002280050566 · DOI
  77. 10.1124/jpet.104.068536 · DOI · Paper page
  78. 10.1007/s10038-004-0188-6 · DOI
  79. 10.1124/dmd.107.015230 · DOI
  80. Prueksaritanont T, 1997, Drug Metab Dispos, 25, 1191
  81. 10.1067/mcp.2001.115542 · DOI · Paper page
  82. 10.1124/jpet.102.041921 · DOI · Paper page
  83. 10.1007/s11095-011-0564-9 · DOI
  84. 10.1517/17425255.4.1.1 · DOI · Paper page
  85. 10.1124/dmd.113.054767 · doi:10.1124/dmd.113.054767
  86. Dobrinska MR, 1988, Pharm Res, 5, S182
  87. Pan HY, 1993, Int J Clin Pharmacol, 31, 291
  88. 10.1002/j.1552-4604.1995.tb04015.x · DOI
  89. 10.1007/BF03190074 · DOI
  90. 10.1016/0002-9343(94)90230-5 · doi:10.1016/0002-9343(94)90230-5
  91. 10.1046/j.1365-2125.1998.00764.x · DOI · Paper page
  92. 10.1016/0140-6736(91)90872-M · DOI · Paper page
  93. 10.1016/S0009-9236(98)90130-8 · DOI · Paper page
  94. 10.1016/S0009-9236(98)90034-0 · DOI · Paper page
  95. 10.1053/cp.1999.v66.100453001 · doi:10.1053/cp.1999.v66.100453001 · Paper page
  96. 10.1111/j.1365-2125.2005.02462.x · DOI
  97. 10.1111/j.1365-2125.2011.03996.x · DOI
  98. 10.2133/dmpk.DMPK-12-RG-067 · DOI
  99. Jacobsen W, 1999, Drug Metab Dispos, 27, 173, 10.1016/S0090-9556(24)15273-7 · DOI
  100. 10.1067/mcp.2000.110216 · DOI · Paper page
  101. Thummel KE, 2001, Mol Pharmacol, 60, 1399, 10.1124/mol.60.6.1399 · DOI · Paper page
  102. 10.1016/S0006-291X(02)02742-0 · DOI
  103. 10.1074/jbc.M201323200 · DOI · Paper page
  104. 10.1007/s00228-003-0700-5 · DOI
  105. 10.1067/mcp.2000.111414 · DOI · Paper page
  106. 10.1046/j.1365-2125.2003.01972.x · DOI
  107. 10.1111/j.1472-8206.2006.00404.x · DOI
  108. 10.1111/bcp.12405 · DOI
  109. 10.1517/14656566.8.14.2315 · DOI
  110. 10.1111/j.1742-1241.2005.00461.x · DOI
  111. 10.1038/clpt.2012.163 · DOI · Paper page
  112. 10.1097/01.qai.0000167156.44980.33 · DOI · Paper page
  113. 10.1177/00912700222011148 · DOI
  114. 10.1016/j.clpt.2005.04.007 · DOI
  115. 10.1016/S0009-9236(98)90023-6 · DOI · Paper page
  116. 10.1067/mcp.2000.110537 · DOI
  117. 10.1111/j.1528-1167.2011.03118.x · doi:10.1111/j.1528-1167.2011.03118.x
  118. 10.1007/s00228-012-1369-4 · DOI
  119. 10.1016/S0009-9236(98)90067-4 · DOI · Paper page
  120. 10.1007/s00228-012-1403-6 · DOI
  121. 10.1007/s002280100298 · doi:10.1007/s002280100298
  122. 10.1016/S0009-9236(98)90151-5 · DOI · Paper page
  123. 10.1016/S0009-9236(98)90165-5 · DOI · Paper page
  124. Gehin M, 2014, Eur J Clin Pharmacol
  125. 10.1016/0002-9149(94)90626-2 · DOI · Paper page
  126. 10.1177/0091270006299138 · DOI
  127. 10.1016/S0002-9149(05)80024-4 · DOI
  128. 10.1093/ajh/6.11.375S · DOI

Cited by

See all 74

Metadata

Authors
Hirota, T., & Ieiri, I.
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2015-06-10
Volume
11
Issue
9
Pages
1435-1447
ISSN
  • 1742-5255
  • 1744-7607
Cited by
74
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug–drug interactions that interfere with statin metabolism. https://app.cochat.ai/papers/10.1517/17425255.2015.1056149
The paper
Hirota, T., & Ieiri, I. (2015). Drug–drug interactions that interfere with statin metabolism. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425255.2015.1056149

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.